Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
Clinical trial NCT01896895 · COMPLETED
Trial details
- NCT number
- NCT01896895
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2016-04-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.